Cargando…

Effectiveness of regdanvimab treatment for SARS-CoV-2 delta variant, which exhibited decreased in vitro activity: a nationwide real-world multicenter cohort study

BACKGROUND: Immune-evading severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants are emerging continuously. The clinical effectiveness of monoclonal antibody agents that exhibit decreased in vitro activity against SARS-CoV-2 variants needs to be elucidated. METHODS: A nationwide, mul...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Haein, Jang, Young Rock, Lee, Ji Yeon, Ko, Jae-Hoon, Lee, Jee Young, Cho, Seongcheol, Lee, Yong Dae, Song, Junghoon, Hyun, Miri, Kim, Hyun Ah, Hwang, Soyoon, Ryou, Sangmi, Na, Yoo Jin, Lee, Joo-Yeon, Lee, Changhee, Lee, Nan Young, Shin, Seunghwan, Kwon, Ki Tae, Kim, Jin Yong, Peck, Kyong Ran
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Cellular and Infection Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10225538/ https://www.ncbi.nlm.nih.gov/pubmed/37256107 http://dx.doi.org/10.3389/fcimb.2023.1192512

Ejemplares similares

Effectiveness of Regdanvimab Treatment in High-Risk COVID-19 Patients to Prevent Progression to Severe Disease
por: Lee, Ji Yeon, et al.
Publicado: (2021)

Regdanvimab for patients with mild-to-moderate COVID-19: a retrospective cohort study and subgroup analysis of patients with the Delta variant
por: Jang, Young Rock, et al.
Publicado: (2023)

Clinical Effectiveness of Regdanvimab Treatment for Mild-to-Moderate COVID-19: A Retrospective Cohort Study
por: Jang, Young Rock, et al.
Publicado: (2022)

Real-World Efficacy of Regdanvimab on Clinical Outcomes in Patients with Mild to Moderate COVID-19
por: Kim, Taeyun, et al.
Publicado: (2022)

Safety and Effectiveness of Regdanvimab for COVID-19 Treatment: A Phase 4 Post-marketing Surveillance Study Conducted in South Korea
por: Lee, Ji Yeon, et al.
Publicado: (2023)

Efficacy and Safety of Regdanvimab (CT-P59): A Phase 2/3 Randomized, Double-Blind, Placebo-Controlled Trial in Outpatients With Mild-to-Moderate Coronavirus Disease 2019
por: Streinu-Cercel, Anca, et al.
Publicado: (2022)

Regdanvimab in patients with mild-to-moderate SARS-CoV-2 infection: A propensity score–matched retrospective cohort study
por: Lee, Shinwon, et al.
Publicado: (2022)

Clinical outcomes of mild to moderate coronavirus disease 2019 patients treated with Regdanvimab in delta-variant outbreak: Retrospective cohort study
por: Noh, Hyeong-Jun, et al.
Publicado: (2023)

Use of the Monoclonal Antibody Regdanvimab to Treat Patients Hospitalized with COVID-19: Real-World Data during the Delta Variant Predominance
por: Kwak, Yee Gyung, et al.
Publicado: (2022)

Early Oxygen Requirement in Patients with Mild-to-Moderate COVID-19 Who Received Regdanvimab after Delta-Variant Outbreak
por: Lee, Chan Mi, et al.
Publicado: (2022)

A Randomized Clinical Trial of Regdanvimab in High-Risk Patients With Mild-to-Moderate Coronavirus Disease 2019
por: Kim, Jin Yong, et al.
Publicado: (2022)

Risk Factors for Mortality and Respiratory Support in Elderly Patients Hospitalized with COVID-19 in Korea
por: Lee, Ji Yeon, et al.
Publicado: (2020)

e-Learning for enhancement of medical student performance at the Objective Structured Clinical Examination (OSCE)
por: Kim, Kyong-Jee, et al.
Publicado: (2021)

Regdanvimab: First Approval
por: Syed, Yahiya Y.
Publicado: (2021)

Comparison of the Characteristics of Asymptomatic and Presymptomatic Patients with Coronavirus Disease 2019 in the Republic of Korea
por: Hyun, Miri, et al.
Publicado: (2021)

Clinical Utility of Sero-Immunological Responses Against SARS-CoV-2 Nucleocapsid Protein During Subsequent Prevalence of Wild-Type, Delta Variant, and Omicron Variant
por: Lee, Beomki, et al.
Publicado: (2023)

Correction to: Regdanvimab: First Approval
por: Syed, Yahiya Y.
Publicado: (2021)

Regdanvimab Treatment of COVID-19
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

546. Therapeutic Effect of Regdanvimab in Patients with Mild to Moderate COVID-19: Day 28 Results from a Multicentre, Randomised, Controlled Pivotal Trial
por: Ison, Michael G, et al.
Publicado: (2021)

Effectiveness of Regdanvimab at Preventing the Need for Oxygen Therapy in Patients with Mild-to-Moderate COVID-19: A Retrospective Cohort Study
por: Choi, Seong Jin, et al.
Publicado: (2022)

Metastatic testicular tumor presenting as a scrotal hydrocele: An initial manifestation of pancreatic adenocarcinoma
por: KIM, YEON WOOK, et al.
Publicado: (2014)

Prolonged viral shedding in severely ill patients infected with SARS-CoV-2 Delta variants: A retrospective cohort study
por: Baek, Yae Jee, et al.
Publicado: (2022)

Neutralizing Activity Against SARS-CoV-2 Delta and Omicron Variants Following a Third BNT162b2 Booster Dose According to Three Homologous or Heterologous COVID-19 Vaccination Schedules
por: Choi, Ju-yeon, et al.
Publicado: (2022)

Primary mucinous cystadenoma of the spermatic cord within the inguinal canal
por: Kim, Jee-Yeon, et al.
Publicado: (2012)

Differences of virulence factors, and antimicrobial susceptibility according to phylogenetic group in uropathogenic Escherichia coli strains isolated from Korean patients
por: Hyun, Miri, et al.
Publicado: (2021)

1318. Clinical and Molecular Characteristics of Hypermucoviscous Klebsiella pneumoniae Causing Pneumonia in Korea
por: Lee, Ji Yeon, et al.
Publicado: (2021)

654. Changing trends of molecular characteristics and antimicrobial susceptibility of hypervirulent Klebsiella pneumoniae in community-acquired liver abscess before and after COVID-19 outbreak in South Korea
por: Hyun, Miri, et al.
Publicado: (2023)

Association of Fasting Glucose Level with Neutrophil-Lymphocyte Ratio Compared to Leukocyte Count and Serum C-Reactive Protein
por: Kim, Jin-Kyu, et al.
Publicado: (2018)

Reply on “Vitamin D and coronary atherosclerosis”
por: Lee, Ah-Young, et al.
Publicado: (2017)

Relationship between coronary atherosclerosis in coronary computed tomography angiography and serum vitamin D level
por: Lee, Ah-Young, et al.
Publicado: (2017)

A risk scoring system to predict progression to severe pneumonia in patients with Covid-19
por: Lee, Ji Yeon, et al.
Publicado: (2022)

Characteristics of COVID-19 Patients Who Progress to Pneumonia on Follow-Up Chest Radiograph: 236 Patients from a Single Isolated Cohort in Daegu, South Korea
por: Jung, Ha Kyung, et al.
Publicado: (2020)

The Natural Alkaloid Palmatine Selectively Induces Mitophagy and Restores Mitochondrial Function in an Alzheimer’s Disease Mouse Model
por: Lee, Da-Ye, et al.
Publicado: (2023)

Korean Red Ginseng reduces chronic social defeat stress-induced mood disorders via N-methyl-D-aspartate receptor modulation in mice
por: Lee, Bo-Ram, et al.
Publicado: (2021)

Development and Characterization of a Reverse Genetics System for a Human-Derived Severe Fever With Thrombocytopenia Syndrome Virus Isolate From South Korea
por: Yun, Seok-Min, et al.
Publicado: (2021)

Pros and Cons of In Vitro Methods for Circular RNA Preparation
por: Lee, Kyung Hyun, et al.
Publicado: (2022)

Child-rearing experiences of mothers with early adolescents in Korean multicultural families
por: Lee, Sangmi, et al.
Publicado: (2021)

Morphine-induced postconditioning modulates mitochondrial permeability transition pore opening via delta-1 opioid receptors activation in isolated rat hearts
por: Kim, June Hong, et al.
Publicado: (2011)

A Novel Visualization Method for Sleep Spindles Based on Source Localization of High Density EEG
por: Lee, Soohyun, et al.
Publicado: (2017)

Mucosal distribution of somatostatin-secreting gastric Delta cells in children with gastrointestinal reflux diseases
por: Kim, Dong-Uk, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_02lvr0gpiuman6eum06rh06ijm